Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

Market Cap	8.10B -16.7%
Revenue (ttm)	2.29B +0.3%
Net Income	219.93M -35.2%
EPS	0.70 -34.7%
Shares Out	311.71M
PE Ratio	37.11
Forward PE	27.20
Dividend	0.33 (1.23%)
Ex-Dividend Date	Jun 18, 2026

Volume	5,055,101
Open	26.93
Previous Close	26.93
Day's Range	25.98 - 27.17
52-Week Range	25.30 - 38.80
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About SHA:688139

Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 2,945
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688139

Financial Performance

In 2025, SHA:688139's revenue was 2.33 billion, an increase of 1.96% compared to the previous year's 2.28 billion. Earnings were 250.73 million, a decrease of -31.61%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 24, 2026

Data Sources Report a data error